BriaCell Therapeutics (TSX:BCT) Days Payable : 0.00 (As of Jan. 2024)

View and export this data going back to 2006. Start your Free Trial

What is BriaCell Therapeutics Days Payable?

BriaCell Therapeutics's average Accounts Payable for the three months ended in Jan. 2024 was C$2.79 Mil. BriaCell Therapeutics's Cost of Goods Sold for the three months ended in Jan. 2024 was C$0.00 Mil.

The historical rank and industry rank for BriaCell Therapeutics's Days Payable or its related term are showing as below:

TSX:BCT's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 149.7
* Ranked among companies with meaningful Days Payable only.

BriaCell Therapeutics's Days Payable stayed the same from Jan. 2023 (0.00) to Jan. 2024 (0.00). stayed the same

BriaCell Therapeutics Days Payable Historical Data

The historical data trend for BriaCell Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics Days Payable Chart

BriaCell Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Days Payable

Get a 7-Day Free Trial

BriaCell Therapeutics Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BriaCell Therapeutics's Days Payable

For the Biotechnology subindustry, BriaCell Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BriaCell Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Days Payable falls into.

BriaCell Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BriaCell Therapeutics's Days Payable for the fiscal year that ended in Jul. 2023 is calculated as

	Days Payable (A: Jul. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jul. 2022 )	+	Accounts Payable (A: Jul. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jul. 2023 )	*	Days in Period
=	( (0.599	+	1.485)	/	2 )	/	0	*	365
=	1.042					/	0	*	365
=	N/A

BriaCell Therapeutics's Days Payable for the quarter that ended in Jan. 2024 is calculated as:

	Days Payable (Q: Jan. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Oct. 2023 )	+	Accounts Payable (Q: Jan. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jan. 2024 )	*	Days in Period
=	( (0.595	+	4.981)	/	2 )	/	0	*	365 / 4
=	2.788					/	0	*	365 / 4
=	N/A

BriaCell Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics (TSX:BCT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (TSX:BCT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BCTX:USA

Address

235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1

Website

https://www.briacell.com

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

Executives

Jamieson Bondarenko

Director

BriaCell Therapeutics (TSX:BCT) Headlines

No Headlines